España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Eupraxia Pharmaceuticals
EPRX
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
Get Report
Comment
Eupraxia Pharmaceuticals (EPRX) Forecast
News
Earnings
Eupraxia Pharmaceuticals (EPRX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Eupraxia Pharmaceuticals (NASDAQ:EPRX) Stock
Eupraxia Pharmaceuticals Stock (NASDAQ: EPRX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, November 20, 2024
Eupraxia Pharmaceuticals shares are trading h...
Benzinga Newsdesk
Eupraxia Pharmaceuticals Unveiled New Pharmac...
Benzinga Newsdesk
Thursday, November 14, 2024
Rodman & Renshaw Initiates Coverage On Euprax...
Benzinga Newsdesk
Tuesday, November 12, 2024
Eupraxia Reports Additional Clinical Data Fro...
Benzinga Newsdesk
Thursday, November 07, 2024
Eupraxia Pharmaceuticals Reports Q3 Net Incom...
Benzinga Newsdesk
Eurpaxia Pharmaceuticals Q3 EPS $(0.17) Up Fr...
Benzinga Newsdesk
Tuesday, October 15, 2024
Eupraxia Pharamceuticals shares are trading h...
Benzinga Newsdesk
Eupraxia Recently Publishes Phase 2 Data From...
Benzinga Newsdesk
Wednesday, September 11, 2024
Eupraxia Pharmaceuticals Announced Additional...
Benzinga Newsdesk
Wednesday, August 07, 2024
Eupraxia Pharmaceuticals Q2 EPS $(0.17) Vs $(...
Benzinga Newsdesk
Wednesday, June 05, 2024
Eupraxia Pharmaceuticals To Present Results F...
Benzinga Newsdesk
Thursday, May 23, 2024
Eupraxia Says Regulators In Australia And Can...
Benzinga Newsdesk
Wednesday, May 22, 2024
Why Urban Outfitters Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Eupraxia Pharmaceuticals shares are trading h...
Benzinga Newsdesk
Tuesday, May 21, 2024
Eupraxia Pharmaceuticals shares are trading h...
Benzinga Newsdesk
Eupraxia Pharmaceuticals Announces Additional...
Benzinga Newsdesk
Thursday, April 11, 2024
Eupraxia Reports Upcoming Presentations At Os...
Benzinga Newsdesk
Monday, April 08, 2024
Why Esperion Therapeutics Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
